Steven Cohen Elevation Oncology, Inc. Transaction History
Point72 Asset Management, L.P.
- $39.3 Billion
- Q1 2024
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Elevation Oncology, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 3,368,200 shares of ELEV stock, worth $9.09 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
3,368,200Holding current value
$9.09 Million% of portfolio
0.04%Shares
4 transactions
Others Institutions Holding ELEV
# of Institutions
65Shares Held
44MCall Options Held
700Put Options Held
0-
Farallon Capital Management LLC San Francisco, CA3.89MShares$10.5 Million0.09% of portfolio
-
Tang Capital Management LLC San Diego, CA3.06MShares$8.26 Million1.91% of portfolio
-
Balyasny Asset Management LLC Chicago, IL3.06MShares$8.25 Million0.03% of portfolio
-
Aisling Capital Management LP New York, NY2.83MShares$7.65 Million4.98% of portfolio
-
Ven Bio Partners LLC San Francisco, CA2.7MShares$7.28 Million5.41% of portfolio
About Elevation Oncology, Inc.
- Ticker ELEV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 23,300,900
- Market Cap $62.9M
- Description
- Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States. The company's lead program is the seribantumab, an anti-HER3 monoclonal antibody that is in Phase II CRESTONE trial for the treatment of advanced sol...